Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Autologous Stem Cell Transplantation for Multiple Myeloma in Algeria

Malek Benakli, Arezki Tibiche, Nabil Yafour, Kamila Amani, Farah Bouamama, Leila Charef, Samira Bouchama, Khadidja Bouhafs, Amel Baki, Soufi Osmani, Mohamed Brahimi, Rachid Bouhass, Abdessamed Arabi, Mohamed Amine Bekadja, Farih Mehdid, Sabrina Akhrouf, Mounira Baazizi, Nadia Rahmoune, Dina Ait Ouali, Hanane Bouarab, Nacera Ait Amer, Farida Tensaout, Rihab Benouattas, Rachida Belhadj, Amina Talbi, Naima Abdennebi, Farida Harieche, Rose-Marie Hamladji, Redhouane Ahmed Nacer, Fatma Soltani, Mahbouba Ferrari, Mahdia Saidi, Salima Oukid, Cherifa Guezlane, Zohor Bouchetara, Mohand Tayeb Abad, Mohamed Bradai, Lina Kazi Tani, Naima Mesli, Mohamed Cherif Rahali, Mohamed Rafik Abadi, Samir Mnaouar, Khadidja Djouadi, Salahedine Belakehal, Samir Baghdad, Aissa Bachiri, Hadjira Ahmidatou, Soraya Kellouche, Nadia Boudjerra, Nawel Ferroudj, Salim Nekkal, Zohra Kaci, Yamina Bouchakor Moussa, Lynda Louanchi, Meriem Bensadok

Blood (2023) 142 (Supplement 1): 4973.

https://doi.org/10.1182/blood-2023-174045

Published: 2023

Journal Articles

Epidemiology and Management of Immune Thrombocytopenia in Adult Patients in Algeria: A Non-Interventional, Longitudinal, Nationwide Estimation Study

Mohamed-Amine Bekadja, Mohamed Bradai, Hocine Ait Ali, Selma Hamdi, Nadia Boudjerra, Mahdia Hocine Saidi, Fatiha Grifi, Djamel Saidi, Naima Mesli, Zahia Zouaoui, Nourredine Lakhdari, Nemra Mehalhal, Noureddine Sidimansour, Ryma Tiaiba, Sarah Lakehal, Hossam A Saad, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-139569

Published: 2020

Journal Articles

Epidemiological, Clinical, and Biological Characterization of Newly Diagnosed Acute Myeloid Leukemia in Algeria. Report on Behalf of the Algerian Acute Leukemia Study Group

Bekadja Med Amine, MD PhD, Amina Krim, MD, Rachid Amar Bouhass, MD PhD, Malika Rekab, MD, Yamina bouchakor Moussa, MD PhD, Souad Taoussi, MD PhD, Mohand Tayed Abad, MD PhD, Mohamed Bradai, MD PhD, Mohamed Graine, MD, Hocine AIT ALI, MD PhD, Imene Bouras, MD, Selma Hamdi, MD PhD, Redhouane Ahmed Nacer, MD PhD, Sabrina Akhrouf, MD, Rose-Marie Hamladji, MD PhD, Yasmina Berkouk, MD PhD, Nadia Boudjerra, MD PhD, Meriem Belhani, MD PhD, Samira Zouani, MD, Djamel Saidi, Hadj Touhami, Soraya Boughrira, MD, Fatiha Grifi, MD PhD, Malika Merrouche, MD, Mahdia Saidi, MD PhD, Brahim Benzineb, Naima Mesli, MD PhD, Sihem Kebaili, MD, Noureddine Sidimansour, MD PhD, Mohamed Mohamed Benlazar, MD, Zahia Zouaoui, MD PhD, Mohamed Aberkane, Aissa Bachiri, MD, Faiza Mezhoud, MD, Yamina Ouarlent, MD PhD, Hichem Gaid, MD, Nemra Mehalhal, MD PhD, Mustapha Talbi, MD, Laid Touati, MD PhD, Nordine Lakhdari, MD PhD, Bassima Bendjaballah, MD PhD, Malika Djillali, MD, Salaheddin Belakehal, MD PhD, Khadija Djouadi, MD PhD, Fatima zohra Ardjoun, MD PhD, Mohamed Ramaoun, MD PhD, Nesrine Benyaa, MD, Salim Nekkal, MD PhD, Salima Oukid, MD PhD, Farih Mehdid, MD PhD, Nacer Ait Ameur, MD PhD, Toufik Yachekour, MD, Malek Benakli, MD PhD, Noureddine Metahri, PhD, Ali Bazarbachi, MD PhD

Blood (2018) 132 (Supplement 1): 5172.

https://doi.org/10.1182/blood-2018-99-116860

Published: 2018

Journal Articles

Phlebotomy and Bolus Subcutaneous Deferoxamine in Algerian Patients with Thalassemia Major or Intermedia or Sickle Cell Disease Treated with Hydroxyurea.

Mohamed Bradai, MD, Dora Bachir, MD, Mariane De Montalembert, MD

Blood (2007) 110 (11): 3812.

https://doi.org/10.1182/blood.V110.11.3812.3812

Published: 2007

Journal Articles

Evolution of Transfusion Requirement in Algerian Thalassemic Major (TM) and Intermediate (TI) Patients Treated with Hydroxyurea (HU).

Mohamed Bradai, MD, Serge Pissard, MD, Mohand Tayeb Abad, MD, Agnes Dechartres, MD, Jean-Antoine Ribeil, MD, Paul Landais, MD, Mariane De Montalembert, MD

Blood (2006) 108 (11): 1588.

https://doi.org/10.1182/blood.V108.11.1588.1588

Published: 2006

Journal Articles

Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia

Mohamed Bradai, Mohand Tayeb Abad, Serge Pissard, Fatima Lamraoui, Laurent Skopinski, Mariane de Montalembert

Blood (2003) 102 (4): 1529–1530.

https://doi.org/10.1182/blood-2003-01-0117

Published: 2003

NARROW

Autologous Stem Cell Transplantation for Multiple Myeloma in Algeria

Epidemiology and Management of Immune Thrombocytopenia in Adult Patients in Algeria: A Non-Interventional, Longitudinal, Nationwide Estimation Study

Epidemiological, Clinical, and Biological Characterization of Newly Diagnosed Acute Myeloid Leukemia in Algeria. Report on Behalf of the Algerian Acute Leukemia Study Group

Phlebotomy and Bolus Subcutaneous Deferoxamine in Algerian Patients with Thalassemia Major or Intermedia or Sickle Cell Disease Treated with Hydroxyurea.

Evolution of Transfusion Requirement in Algerian Thalassemic Major (TM) and Intermediate (TI) Patients Treated with Hydroxyurea (HU).

Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia

Email alerts

ASH Publications

American Society of Hematology

Autologous Stem Cell Transplantation for Multiple Myeloma in Algeria

Epidemiology and Management of Immune Thrombocytopenia in Adult Patients in Algeria: A Non-Interventional, Longitudinal, Nationwide Estimation Study

Epidemiological, Clinical, and Biological Characterization of Newly Diagnosed Acute Myeloid Leukemia in Algeria. Report on Behalf of the Algerian Acute Leukemia Study Group

Phlebotomy and Bolus Subcutaneous Deferoxamine in Algerian Patients with Thalassemia Major or Intermedia or Sickle Cell Disease Treated with Hydroxyurea.

Evolution of Transfusion Requirement in Algerian Thalassemic Major (TM) and Intermediate (TI) Patients Treated with Hydroxyurea (HU).

Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only